Selected research
Market Structure
Global Whole Plasmid Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Whole Plasmid Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Whole Plasmid Sequencing include Eurofins Genomics, GenScript, Plasmidsaurus, Genewiz, Macrogen Europe, Source BioScience, Psomagen, BaseClear B.V. and Molecular Cloning Laboratories (MCLAB), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Whole Plasmid Sequencing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Whole Plasmid Sequencing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Whole Plasmid Sequencing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Whole Plasmid Sequencing market size, projected growth trends, production technologies, key applications, and end-use industries.
Whole Plasmid Sequencing Segment by Company
Eurofins Genomics
GenScript
Plasmidsaurus
Genewiz
Macrogen Europe
Source BioScience
Psomagen
BaseClear B.V.
Molecular Cloning Laboratories (MCLAB)
Polyplus
Elim Biopharm
SnapGene
Full Circle Labs
Unveil Bio
Microsynth AG
CD Genomics
Whole Plasmid Sequencing Segment by Type
Plasmid Regular (2.5 – 25 kb)
Plasmid Large (25 – 125 kb)
Plasmid XL (125 – 300 kb)
Others
Whole Plasmid Sequencing Segment by Application
Biopharmaceutical Companies
Research Institutions
Others
Whole Plasmid Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Plasmid Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Plasmid Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Plasmid Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Whole Plasmid Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Plasmid Sequencing industry.
Chapter 3: Detailed analysis of Whole Plasmid Sequencing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Plasmid Sequencingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasmid Regular (2.5 – 25 kb)
- Plasmid Large (25 – 125 kb)
- Plasmid XL (125 – 300 kb)
- Others
Applications
- Biopharmaceutical Companies
- Research Institutions
- Others
Companies covered
- Eurofins Genomics
- GenScript
- Plasmidsaurus
- Genewiz
- Macrogen Europe
- Source BioScience
- Psomagen
- BaseClear B.V.
- Molecular Cloning Laboratories (MCLAB)
- Polyplus
- Elim Biopharm
- SnapGene
- Full Circle Labs
- Unveil Bio
- Microsynth AG
- CD Genomics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Whole Plasmid Sequencing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Plasmid Regular (2.5 – 25 kb)
- 1.2.3 Plasmid Large (25 – 125 kb)
- 1.2.4 Plasmid XL (125 – 300 kb)
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Whole Plasmid Sequencing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Biopharmaceutical Companies
- 1.3.3 Research Institutions
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Whole Plasmid Sequencing Growth Trends by Region
- 1.5.1 Global Whole Plasmid Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Whole Plasmid Sequencing Market Size by Region (2021-2026)
- 1.5.3 Whole Plasmid Sequencing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Whole Plasmid Sequencing Market Dynamics
- 2.1 Whole Plasmid Sequencing Industry Trends
- 2.2 Whole Plasmid Sequencing Industry Drivers
- 2.3 Whole Plasmid Sequencing Industry Opportunities and Challenges
- 2.4 Whole Plasmid Sequencing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Whole Plasmid Sequencing Revenue by Company (2021-2026)
- 3.2 Global Whole Plasmid Sequencing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Whole Plasmid Sequencing Key Company Head office and Area Served
- 3.4 Global Whole Plasmid Sequencing Company, Product Type & Application
- 3.5 Global Whole Plasmid Sequencing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Whole Plasmid Sequencing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Whole Plasmid Sequencing Players Market Share by Revenue in 2025
- 3.6.3 2025 Whole Plasmid Sequencing Tier 1, Tier 2, and Tier 3
4 Whole Plasmid Sequencing Market by Type
- 4.1 Global Whole Plasmid Sequencing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Whole Plasmid Sequencing Market Size by Type (2021-2032)
- 4.3 Global Whole Plasmid Sequencing Market Size Share by Type (2021-2032)
5 Whole Plasmid Sequencing Market by Application
- 5.1 Global Whole Plasmid Sequencing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Whole Plasmid Sequencing Market Size by Application (2021-2032)
- 5.3 Global Whole Plasmid Sequencing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Eurofins Genomics
- 6.1.1 Eurofins Genomics Company Information
- 6.1.2 Eurofins Genomics Business Overview
- 6.1.3 Eurofins Genomics Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Eurofins Genomics Whole Plasmid Sequencing Product Portfolio
- 6.1.5 Eurofins Genomics Recent Developments
- 6.2 GenScript
- 6.2.1 GenScript Company Information
- 6.2.2 GenScript Business Overview
- 6.2.3 GenScript Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 GenScript Whole Plasmid Sequencing Product Portfolio
- 6.2.5 GenScript Recent Developments
- 6.3 Plasmidsaurus
- 6.3.1 Plasmidsaurus Company Information
- 6.3.2 Plasmidsaurus Business Overview
- 6.3.3 Plasmidsaurus Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Plasmidsaurus Whole Plasmid Sequencing Product Portfolio
- 6.3.5 Plasmidsaurus Recent Developments
- 6.4 Genewiz
- 6.4.1 Genewiz Company Information
- 6.4.2 Genewiz Business Overview
- 6.4.3 Genewiz Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Genewiz Whole Plasmid Sequencing Product Portfolio
- 6.4.5 Genewiz Recent Developments
- 6.5 Macrogen Europe
- 6.5.1 Macrogen Europe Company Information
- 6.5.2 Macrogen Europe Business Overview
- 6.5.3 Macrogen Europe Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Macrogen Europe Whole Plasmid Sequencing Product Portfolio
- 6.5.5 Macrogen Europe Recent Developments
- 6.6 Source BioScience
- 6.6.1 Source BioScience Company Information
- 6.6.2 Source BioScience Business Overview
- 6.6.3 Source BioScience Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Source BioScience Whole Plasmid Sequencing Product Portfolio
- 6.6.5 Source BioScience Recent Developments
- 6.7 Psomagen
- 6.7.1 Psomagen Company Information
- 6.7.2 Psomagen Business Overview
- 6.7.3 Psomagen Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Psomagen Whole Plasmid Sequencing Product Portfolio
- 6.7.5 Psomagen Recent Developments
- 6.8 BaseClear B.V.
- 6.8.1 BaseClear B.V. Company Information
- 6.8.2 BaseClear B.V. Business Overview
- 6.8.3 BaseClear B.V. Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 BaseClear B.V. Whole Plasmid Sequencing Product Portfolio
- 6.8.5 BaseClear B.V. Recent Developments
- 6.9 Molecular Cloning Laboratories (MCLAB)
- 6.9.1 Molecular Cloning Laboratories (MCLAB) Company Information
- 6.9.2 Molecular Cloning Laboratories (MCLAB) Business Overview
- 6.9.3 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Product Portfolio
- 6.9.5 Molecular Cloning Laboratories (MCLAB) Recent Developments
- 6.10 Polyplus
- 6.10.1 Polyplus Company Information
- 6.10.2 Polyplus Business Overview
- 6.10.3 Polyplus Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Polyplus Whole Plasmid Sequencing Product Portfolio
- 6.10.5 Polyplus Recent Developments
- 6.11 Elim Biopharm
- 6.11.1 Elim Biopharm Company Information
- 6.11.2 Elim Biopharm Business Overview
- 6.11.3 Elim Biopharm Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Elim Biopharm Whole Plasmid Sequencing Product Portfolio
- 6.11.5 Elim Biopharm Recent Developments
- 6.12 SnapGene
- 6.12.1 SnapGene Company Information
- 6.12.2 SnapGene Business Overview
- 6.12.3 SnapGene Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 SnapGene Whole Plasmid Sequencing Product Portfolio
- 6.12.5 SnapGene Recent Developments
- 6.13 Full Circle Labs
- 6.13.1 Full Circle Labs Company Information
- 6.13.2 Full Circle Labs Business Overview
- 6.13.3 Full Circle Labs Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Full Circle Labs Whole Plasmid Sequencing Product Portfolio
- 6.13.5 Full Circle Labs Recent Developments
- 6.14 Unveil Bio
- 6.14.1 Unveil Bio Company Information
- 6.14.2 Unveil Bio Business Overview
- 6.14.3 Unveil Bio Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Unveil Bio Whole Plasmid Sequencing Product Portfolio
- 6.14.5 Unveil Bio Recent Developments
- 6.15 Microsynth AG
- 6.15.1 Microsynth AG Company Information
- 6.15.2 Microsynth AG Business Overview
- 6.15.3 Microsynth AG Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Microsynth AG Whole Plasmid Sequencing Product Portfolio
- 6.15.5 Microsynth AG Recent Developments
- 6.16 CD Genomics
- 6.16.1 CD Genomics Company Information
- 6.16.2 CD Genomics Business Overview
- 6.16.3 CD Genomics Whole Plasmid Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 CD Genomics Whole Plasmid Sequencing Product Portfolio
- 6.16.5 CD Genomics Recent Developments
7 North America
- 7.1 North America Whole Plasmid Sequencing Market Size (2021-2032)
- 7.2 North America Whole Plasmid Sequencing Market Size by Type
- 7.2.1 North America Whole Plasmid Sequencing Market Size by Type (2021-2026)
- 7.2.2 North America Whole Plasmid Sequencing Market Size by Type (2027-2032)
- 7.2.3 North America Whole Plasmid Sequencing Market Share by Type (2021-2032)
- 7.3 North America Whole Plasmid Sequencing Market Size by Application
- 7.3.1 North America Whole Plasmid Sequencing Market Size by Application (2021-2026)
- 7.3.2 North America Whole Plasmid Sequencing Market Size by Application (2027-2032)
- 7.3.3 North America Whole Plasmid Sequencing Market Share by Application (2021-2032)
- 7.4 North America Whole Plasmid Sequencing Market Size by Country
- 7.4.1 North America Whole Plasmid Sequencing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 7.4.3 North America Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 7.4.4 North America Whole Plasmid Sequencing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Whole Plasmid Sequencing Market Size (2021-2032)
- 8.2 Europe Whole Plasmid Sequencing Market Size by Type
- 8.2.1 Europe Whole Plasmid Sequencing Market Size by Type (2021-2026)
- 8.2.2 Europe Whole Plasmid Sequencing Market Size by Type (2027-2032)
- 8.2.3 Europe Whole Plasmid Sequencing Market Share by Type (2021-2032)
- 8.3 Europe Whole Plasmid Sequencing Market Size by Application
- 8.3.1 Europe Whole Plasmid Sequencing Market Size by Application (2021-2026)
- 8.3.2 Europe Whole Plasmid Sequencing Market Size by Application (2027-2032)
- 8.3.3 Europe Whole Plasmid Sequencing Market Share by Application (2021-2032)
- 8.4 Europe Whole Plasmid Sequencing Market Size by Country
- 8.4.1 Europe Whole Plasmid Sequencing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 8.4.3 Europe Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 8.4.4 Europe Whole Plasmid Sequencing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Whole Plasmid Sequencing Market Size (2021-2032)
- 9.2 China Whole Plasmid Sequencing Market Size by Type
- 9.2.1 China Whole Plasmid Sequencing Market Size by Type (2021-2026)
- 9.2.2 China Whole Plasmid Sequencing Market Size by Type (2027-2032)
- 9.2.3 China Whole Plasmid Sequencing Market Share by Type (2021-2032)
- 9.3 China Whole Plasmid Sequencing Market Size by Application
- 9.3.1 China Whole Plasmid Sequencing Market Size by Application (2021-2026)
- 9.3.2 China Whole Plasmid Sequencing Market Size by Application (2027-2032)
- 9.3.3 China Whole Plasmid Sequencing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Whole Plasmid Sequencing Market Size (2021-2032)
- 10.2 Asia Whole Plasmid Sequencing Market Size by Type
- 10.2.1 Asia Whole Plasmid Sequencing Market Size by Type (2021-2026)
- 10.2.2 Asia Whole Plasmid Sequencing Market Size by Type (2027-2032)
- 10.2.3 Asia Whole Plasmid Sequencing Market Share by Type (2021-2032)
- 10.3 Asia Whole Plasmid Sequencing Market Size by Application
- 10.3.1 Asia Whole Plasmid Sequencing Market Size by Application (2021-2026)
- 10.3.2 Asia Whole Plasmid Sequencing Market Size by Application (2027-2032)
- 10.3.3 Asia Whole Plasmid Sequencing Market Share by Application (2021-2032)
- 10.4 Asia Whole Plasmid Sequencing Market Size by Country
- 10.4.1 Asia Whole Plasmid Sequencing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 10.4.3 Asia Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 10.4.4 Asia Whole Plasmid Sequencing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Whole Plasmid Sequencing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Type
- 11.2.1 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Whole Plasmid Sequencing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Application
- 11.3.1 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Whole Plasmid Sequencing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Country
- 11.4.1 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Whole Plasmid Sequencing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Whole Plasmid Sequencing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst